CORONARY-THROMBOSIS - PATHOGENESIS AND CLINICAL MANIFESTATIONS

被引:161
作者
FALK, E
机构
[1] University Institute of Forensic Medicine, Odense
关键词
D O I
10.1016/0002-9149(91)90382-U
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The majority (> 75%) of major coronary thrombi are precipitated by a sudden rupture of the surface of an atherosclerotic plaque (plaque fissuring) causing platelet aggregation where thrombogenic subendothelial tissue has been exposed. Whether the thrombus remains mural and limited, just sealing the rupture, or evolves into an occlusive thrombus seems to depend on: (1) the amount and character of exposed thrombogenic material; (2) the actual thrombotic-thrombolytic equilibrium; and (3) local flow disturbances due to preexisting atherosclerotic stenosis. Thrombus formation may take place within the stenosis, where blood velocity and shear forces are highest, or it may take place or extend poststenotically, where flow separation, recirculation, and turbulence prevail. Platelet aggregation within the stenosis is responsible for the primary flow obstruction, but fibrin subsequently enmeshes the platelets and thus stabilizes the thrombus. Most thrombi have a layered structure, indicating an episodic growth that may alternate with thrombus fragmentation and peripheral embolization: thrombosis and thrombolysis are dynamic processes occurring simultaneously. If the platelet-rich thrombus at the rupture site evolves into an occlusive thrombus, the blood proximal and distal to the occlusion may stagnate and coagulate, giving rise to a secondarily formed red stagnation thrombosis consisting predominantly of erythrocytes held together by fibrin membranes. A ruptured plaque with a dynamic thrombosis superimposed (with or without spasm) seems to underlie the great majority of acute ischemic syndromes: unstable angina, acute infarction, and sudden death. The clinical presentation and the outcome depend on the severity and duration of ischemia: whether the obstruction is occlusive or nonocclusive, transient or persistent-modified by the magnitude of collateral flow.
引用
收藏
页码:B28 / B35
页数:8
相关论文
共 70 条
[41]   PREEXISTING CORONARY STENOSES IN PATIENTS WITH 1ST MYOCARDIAL-INFARCTION ARE NOT NECESSARILY SEVERE [J].
HACKETT, D ;
DAVIES, G ;
MASERI, A .
EUROPEAN HEART JOURNAL, 1988, 9 (12) :1317-1323
[42]  
HANGARTNER JRW, 1986, BRIT HEART J, V56, P501
[43]   RETHROMBOSIS AFTER REPERFUSION WITH STREPTOKINASE - IMPORTANCE OF GEOMETRY OF RESIDUAL LESIONS [J].
HARRISON, DG ;
FERGUSON, DW ;
COLLINS, SM ;
SKORTON, DJ ;
ERICKSEN, EE ;
KIOSCHOS, JM ;
MARCUS, ML ;
WHITE, CW .
CIRCULATION, 1984, 69 (05) :991-999
[44]   FORMATION AND REGULATION OF PLATELET AND FIBRIN HEMOSTATIC PLUG [J].
HAWIGER, J .
HUMAN PATHOLOGY, 1987, 18 (02) :111-122
[45]   CALCIUM-CHANNEL BLOCKERS IN ACUTE MYOCARDIAL-INFARCTION AND UNSTABLE ANGINA - AN OVERVIEW [J].
HELD, PH ;
YUSUF, S ;
FURBERG, CD .
BMJ-BRITISH MEDICAL JOURNAL, 1989, 299 (6709) :1187-1192
[46]   EFFECTS OF THROMBIN INHIBITION ON THE DEVELOPMENT OF ACUTE PLATELET-THROMBUS DEPOSITION DURING ANGIOPLASTY IN PIGS - HEPARIN VERSUS RECOMBINANT HIRUDIN, A SPECIFIC THROMBIN INHIBITOR [J].
HERAS, M ;
CHESEBRO, JH ;
PENNY, WJ ;
BAILEY, KR ;
BADIMON, L ;
FUSTER, V .
CIRCULATION, 1989, 79 (03) :657-665
[47]   ACETYLSALICYCLIC ACID 100 MG AND 1000 MG DAILY IN ACUTE MYOCARDIAL-INFARCTION SUSPECTS - A PLACEBO-CONTROLLED TRIAL [J].
HUSTED, SE ;
NIELSEN, HK ;
KRUSELL, LR ;
FAERGEMAN, O .
JOURNAL OF INTERNAL MEDICINE, 1989, 226 (05) :303-310
[48]   PREVENTION OF PLATELET-RICH ARTERIAL THROMBOSIS BY SELECTIVE THROMBIN INHIBITION [J].
JANG, IK ;
GOLD, HK ;
ZISKIND, AA ;
LEINBACH, RC ;
FALLON, JT ;
COLLEN, D .
CIRCULATION, 1990, 81 (01) :219-225
[49]  
JORGENSEN L, 1967, AM J PATHOL, V51, P681
[50]   SELECTIVE DECREASE IN LYSIS OF OLD THROMBI AFTER RAPID ADMINISTRATION OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR [J].
KANAMASA, K ;
WATANABE, I ;
CERCEK, B ;
YANO, J ;
FISHBEIN, MC ;
GANZ, W .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1989, 14 (05) :1359-1364